- Home
- Gynaecological Oncology
- Biotech startups Tzar Labs and Epigeneres Biotechnology discover a novel blood test for cancer detection

20212 min read
Medical Article
Biotech startups Tzar Labs and Epigeneres Biotechnology have co-developed a novel blood test called HrC, which can help in the detection of cancers even before symptoms or tumours start developing. Tzar Labs, a Singapore-based molecular diagnostics startup, and Epigeneres Biotechnology, a Mumbai-based biotechnology company, claim to have discovered

Biotech startups Tzar Labs and Epigeneres Biotechnology discover a novel blood test for cancer detection
20 Reached
Similar Content

Black Lesion in Old Female
1970 Reached5 Comments11 Likes

Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1007 Reached2 Comments

Treatment of Recurrent Adult Medulloblastoma
2601 Reached1 Comments4 Likes

Management of Metastatic Prostate Cancer
1037 Reached5 Comments2 Likes

Pancytopenia, a rare presentation of hyperthyroidism
830 Reached2 Comments